ChLIA-based tests for detection of antibodies against Borrelia and Epstein-Barr Virus now available on EUROIMMUN RA Analyzer 10 System WALTHAM, Mass. – July 10, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and... Read more
AuroFlow AQ Afla™ Strip Test Delivers Accurate In-Field or Lab Results in Six Minutes WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its AuroFlow™ AQ Afla strip test, which helps lab professionals, technicians and farmers quickly and accurately conduct first-round screening for toxic compounds in corn.... Read more
DA 6200™ provides processors of meat and olives improved quality and process control WALTHAM, Massachusetts – May 6, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has launched the DA 6200™ NIR analyzer, which will help meat and olive processors to conduct quality and process... Read more
Underscores Commitment to Growth in Singapore with Office in JTC MedTech Hub WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the opening of a new office facility in Singapore. WHEN & WHERE: PerkinElmer held a ribbon cutting ceremony to commemorate the opening of its facility in JTC MedTech Hub, a... Read more
Announcement at 2019 Bio-IT World Conference & Expo syncs with PerkinElmer’s strategy to get labs from big data overload to research insights faster and easier WALTHAM, Massachusetts – April 16, 2019 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has joined Accenture’s open partner ecosystem, designed... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 11, 2019– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that on Thursday, April 25, 2019, after market close, the Company will release first quarter 2019 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss... Read more
Available in Helix’s DNA marketplace, GenePrism: Actionable Insights is the first clinical-grade DNA test available to health individuals that analyzes all 59 medically actionable genes identified by the American College of Medical Genetics and Genomics WALTHAM, Massachusetts – April 2, 2019 – Today, in collaboration with Helix, PerkinElmer, Inc., a global leader committed to innovating... Read more
Serological testing plays critical role in helping diagnose patients with celiac disease WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN Anti-TissueTransglutaminase (tTG) ELISA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The test system is designed to help clinicians confirm or exclude... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Feb. 22, 2019– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Cowen and Company 39th Annual Health Care Conference onMonday, March 11, 2019, at 1:30 p.m. ET at the Marriott Copley Place in Boston. Prahlad Singh, PerkinElmer’s president... Read more
Emerald Test badges validate PerkinElmer’s analytical instruments and testing methods for measuring pesticides, heavy metals, residual solvents, terpenes and potency WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it was awarded five “Emerald Test” badges for proficiency in cannabis testing, as part of Emerald Scientific’s bi-annual Inter-Laboratory Comparison... Read more